RecruitingOBSERVATIONAL

PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer

This study, called the PROMISE PET Registry, wants to understand how a special type of scan, known as a PSMA-PET scan, helps predict what might happen with prostate cancer. Doctors are looking at patients who have had this scan for their prostate cancer to see if it can give a better idea of a patient's outlook. They are comparing the results of the PSMA-PET scan with other standard ways doctors predict how the cancer might behave. The goal is to improve how doctors understand and manage prostate cancer at various stages. By studying many patient records, they hope to find out if the PSMA-PET scan is a valuable tool in helping both patients and doctors make more informed decisions about treatment and care.

At a glance

Status

Recruiting

Sponsor

University Hospital, Essen

Enrolment target

10,000

Start

05 Mar 2024

Estimated completion

05 Mar 2035

Prostate Cancer PET/CT Survivorship PSMA

What is this study about?

This study is called the PROMISE PET Registry, and it's all about understanding prostate cancer better using a special scan. Doctors want to see how a scan called a PSMA-PET scan can help predict what might happen to people with prostate cancer. They're looking at records of patients who have already had this scan at different stages of their cancer journey.

Think of it like this: when you go to the doctor, they do tests to figure out what's going on. For prostate cancer, there are already ways to understand how serious it is and what might happen next. This study is trying to see if the PSMA-PET scan is even better at predicting future outcomes compared to the usual tests. This information is really important because it helps doctors choose the best treatment plans for each patient.

The main idea is to collect information from lots of patient records to see if the PSMA-PET scan helps doctors make more accurate predictions. If it does, it could mean better guidance for treatment and care for people with prostate cancer in the future. The study is particularly interested in whether the scan can give good information for people at all different stages of prostate cancer, from newly diagnosed to those whose cancer has returned or spread.

Key takeaways

This study uses existing medical records, not new tests.
It aims to see if PSMA-PET scans predict prostate cancer outlook better.
The goal is to improve prostate cancer management and treatment decisions.
Your medical information could help many future patients.
No direct involvement or new procedures for participants.

Who may be eligible?

This study is looking for information from adult men who have prostate cancer that has been confirmed by a biopsy (a small tissue sample). You would be included if you've already had a special scan called a PSMA-PET scan to help stage your cancer or see if it has come back.

To be part of the study, there needs to be at least three years of information available on how you've been since your PSMA-PET scan. This helps the researchers understand the long-term effects and outlook.

However, you wouldn't be included if you have a very rare type of prostate cancer called neuroendocrine prostate cancer, or if you also have another type of cancer that has spread.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you an adult with prostate cancer confirmed by a biopsy?
Have you previously had a PSMA-PET scan for your prostate cancer?
Is there at least 3 years of follow-up information available since your scan?
Do you not have neuroendocrine prostate cancer?
Do you not have any other cancer that has spread?

Answer every question to see your result.

What does participation involve?

This is a "registry" study, which means it gathers information from existing patient records rather than asking you to do anything new. You wouldn’t need extra visits, assessments, or take any new medication as part of this study. Researchers will look at information already collected about your prostate cancer diagnosis, your PSMA-PET scan results, and how you’ve been doing over at least three years since your scan.

Essentially, your past medical information would help contribute to a larger database. This database helps doctors understand patterns and improve care for others in the future. There's no direct interaction or special follow-up required from you for this study.

Potential risks and benefits

There are no direct risks or benefits to you if your information is included in this study, as it only involves reviewing your existing medical records. You won't undergo any new treatments or procedures. The potential benefit is that the knowledge gained from your information, combined with many others, could help doctors worldwide better understand and manage prostate cancer, potentially leading to improved care for future patients. You always have the right to withdraw your consent for your anonymised data to be used in the study, even if it has already begun.

Locations (1)

University Hospital Essen
Verified postcode
Essen, Germany· Recruiting

Common questions

What is a PSMA-PET scan?

It's a special type of scan that helps doctors see prostate cancer cells more clearly in the body.

Why is this study important for people with prostate cancer?

It helps doctors understand if the PSMA-PET scan can give a better prediction of how prostate cancer might develop, which can lead to better treatment plans.

Do I need to do anything if my information is used?

No, you don't need to do anything. This study only looks at your existing medical records, so no extra appointments or tests are needed.

Who is looking at my medical information?

Authorised researchers will analyse anonymised medical records to understand patterns and trends, ensuring your personal details are protected.

What does 'prognostic value' mean?

It means how well a test or scan can predict what might happen with a disease in the future.

How to find out more

Wolfgang P Fendler, M.D.

redcap@ikim.nrw +492017232032 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.